Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons

Life Sciences

Volumn 59, Issue 12, 1996, Pages

  French, Edward D ^a   Dillon, Kathryn ^a   Ali, Syed F ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b National Center for Toxicology Research   (United States)

Author keywords

Cocaine; Ibogaine; Morphine; Ventral tegmental dopamine neurons

Indexed keywords

COCAINE; IBOGAINE; INDOLE ALKALOID; MORPHINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; RAT; VENTRAL TEGMENTUM;

EID: 0030590238     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00412-2     Document Type: Article

References (17)

1. 1. H. LOTSOF, Patent No.4, 587,253 (1986).
2. 2. S.D. GLICK, M.E. KUEHNE, J. RAUCCI, T.E. WILSON, D. LARSON, R.W. KELLER JR. and J.N. CARLSON, Brain Res. 657 14-22 (1994).
3. 3. H. SERSHEN, A. HASHIM, L.G. HARSING JR., and A. LAJTHA, Life Sci. 50 1079-1086 (1992).
4. 4. I.M. MAISONNEUVE and S.D. GLICK, Eur. J. Pharm. 212 262-266 (1992).
5. 5. H. SERSHEN, L.G. HARSING JR., A. HASHIM and A. LAJTHA, Life Sci 51: 1003-1011 (1992a).
6. 6. I.M. MAISONNEUVE, R.W. KELLER, JR and S.D. GLICK, Eur.J.Pharm. 199 35-42, (1991).
7. 7. I.M. MAISONNEUVE, R.W. KELLER JR., and S.D. GLICK, Brain Res. 579 87-92, (1992a).
8. 8. P.A. BRODERICK, F.T. PHELAN, F. ENG and R.T. WECHSLER, Pharm. Biochem. Behav. 49 711-728 (1994).
9. 9. P.A. BRODERICK, F.T. PHELAN and S.P. BERGER, NIDA Res. Monograph 119 285 (1992).
10. 10. D.C. DEECHER, M. TEITLER, D.M. SODERLUND, W.G. BORNMANN, M.E. KUEHNE and S.D. GLICK, Brain Res. 571 242-247 (1992).
11. 11. P. POPIK, R.T. LAYER, and P. SKOLNICK, Psychopharmacol. 114 672-674 (1994).
12. 12. E.D. FRENCH, A. MURA and T. WANG, Synapse 13 108-116 (1993).
13. 13. I.M. MAISONNEUVE, K.L. ROSSMAN, R.W. KELLER JR. and S.D. GLICK, Brain Res. 575 69-73 (1992).
14. 14. S.L.T. CAPPENDIJK, and M.R. DZOLJIC, Eur.J.Pharm. 241 261-265 (1993).
15. 15. A.H. REZVANI, D.H. OVERSTREET, and Y-W. LEE, Pharm.Biochem.Behav. 52 615-620 (1995).
16. 16. E.E. MASH, J.K. STALEY, J.P. PABLO, A.M. HOLOHEAN, J.C. HACKMAN and R.A. DAVIDOFF, Neurosci.Letts. 192 53-56 (1995).
17. 17. S.D. GLICK, K. ROSSMAN, S. STEINDORF, I.M. MAISONNEUVE and J.N. CRLSON, Eur.J.Pharm. 195 341-345 (1991).